Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Depression 2Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Breast Neoplasms 1Breast Cancer Surgery 1Anxiety Disorders 1

Interventions

Bupivacaine 18Ropivacaine 10Saline Solution 9Dexmedetomidine 9Sodium Chloride 5Pregabalin 5Morphine 5Ketamine 5Lidocaine 4Dexamethasone 4Control Groups 4Analgesia, Patient-Controlled 4Tea 3Gabapentin 3Anesthetics, Local 3Acetaminophen 3Population Groups 2Parapsychology 2Magnesium Sulfate 2Injections, Epidural 2Fentanyl 2Dental Occlusion 2Anti-Inflammatory Agents, Non-Steroidal 2Analgesics, Opioid 2thiamine triphosphorate 1ramosetron 1parecoxib 1gamma-Aminobutyric Acid 1esmolol 1Water 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pain, Postoperative × Esketamine × Clear all
NCT05096468 2023-07-06

Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.

Beijing Tiantan Hospital

Phase 2/3 Completed
90 enrolled
CNS

Pain, Postoperative, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡